Voyager Therapeutics is trading at $1.95, down -5.58%, in line with weaker biotech-sector sentiment and broader-market declines.
- The provided context shows XBI down 2.06%, while major U.S. indexes are also lower.
- No clear company-specific announcement explaining the October 16 decline was identified; October 15 investor-presentation coverage does not establish a cause.